BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 23400849)

  • 21. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 22. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
    Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
    Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Wlodarski R; Seibert K; Issa NP; O'Brien-Penney B; Soliven B; Sarswat N; Appelbaum D; Rezania K
    Muscle Nerve; 2023 Feb; 67(2):111-116. PubMed ID: 36222831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
    Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL
    J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
    ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment.
    Jerome S; Farrell MB; Warren J; Embry-Dierson M; Schockling EJ
    J Nucl Med Technol; 2023 Jun; 51(2):102-116. PubMed ID: 37268322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.
    Takahashi K; Iwamura T; Hiratsuka Y; Sasaki D; Yamamura N; Ueda M; Morioka H; Yoshino M; Enomoto D; Uemura S; Okura T; Sakaue T; Ikeda S
    Intern Med; 2024 Jun; 63(11):1575-1584. PubMed ID: 37899242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral Multiple Fractures Obstruct Quantitation of 99m Tc-Pyrophosphate Imaging for Cardiac Amyloidosis.
    Zhou Q; Zuo J; Xiao L; Jiang L; Zhao Z
    Clin Nucl Med; 2024 Jul; 49(7):e362-e363. PubMed ID: 38651782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.
    Stats MA; Stone JR
    Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New quantitative indices of cardiac amyloidosis with
    Matsuda N; Otsuka H; Otani T; Azane S; Kunikane Y; Otomi Y; Ueki Y; Kubota M; Amano M; Yagi S; Sata M; Harada M
    Jpn J Radiol; 2023 Apr; 41(4):428-436. PubMed ID: 36449252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?
    Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV
    Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
    Asif T; Gomez J; Singh V; Doukky R; Nedeltcheva A; Malhotra S
    J Nucl Cardiol; 2021 Feb; 28(1):104-111. PubMed ID: 32901418
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
    Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthyretin amyloid cardiomyopathy disease burden quantified using
    Watanabe S; Nakajima K; Toshima F; Wakabayashi H; Yoshida S; Yoneyama H; Komatsu J; Konishi T; Kinuya S
    J Nucl Cardiol; 2023 Dec; 30(6):2721-2735. PubMed ID: 37605060
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
    Castaño A; Bokhari S; Brannagan TH; Wynn J; Maurer MS
    Amyloid; 2012 Mar; 19(1):41-6. PubMed ID: 22149423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric evaluation of
    Watanabe S; Nakajima K; Wakabayashi H; Yoneyama H; Yoshida S; Komatsu J; Konishi T; Inaki A; Kinuya S
    J Nucl Cardiol; 2022 Dec; 29(6):3102-3110. PubMed ID: 34907500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
    Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
    Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of disappearing amyloid on technetium pyrophosphate scan.
    Wang A; Mahmood U; Tang X; Jain D; Pan S
    J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative
    Yabut J; Nadig V; Arora S; Hirsch D; Duvall WL
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e015734. PubMed ID: 38146653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.